TrialJournal of the American Heart Association2013

Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients.

Makoto Ayaori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.